Ayala Pharmaceuticals EBIT margin
¿Qué es el EBIT margin de Ayala Pharmaceuticals?
El EBIT margin de Ayala Pharmaceuticals Inc. es -5,723.60%
¿Cuál es la definición de EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin de compañías en Sector Health Care en NASDAQ en comparadas con Ayala Pharmaceuticals
¿Qué hace Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Empresas con ebit margin similar a Ayala Pharmaceuticals
- Entheon Biomedical tiene EBIT margin de -6,027.18%
- Green Hygienics tiene EBIT margin de -6,022.25%
- VYNE Therapeutics tiene EBIT margin de -5,849.18%
- Desert Metals tiene EBIT margin de -5,802.10%
- Rafael Inc tiene EBIT margin de -5,782.78%
- Clene Nanomedicine tiene EBIT margin de -5,778.73%
- Ayala Pharmaceuticals tiene EBIT margin de -5,723.60%
- Touchpoint tiene EBIT margin de -5,664.29%
- Lyra Therapeutics tiene EBIT margin de -5,567.64%
- Proseed India tiene EBIT margin de -5,566.02%
- Energous Corp tiene EBIT margin de -5,285.48%
- Orgenesis Inc tiene EBIT margin de -5,274.17%
- Zonetail tiene EBIT margin de -5,268.44%